In contrast to the mouse model, a recent study described significantly increased levels of IFN-γ in both CSF and serum of ALS patients [45], highlighting the inherent differences in disease mechanisms between human disease and SOD1 rodent models, and supporting the need to examine the CP in the human disease. The gene discussed is CP; the disease is amyotrophic lateral sclerosis.